Description

🖼️ Tool Name:
Immunai

🔖 Tool Category:
Forecasting & Applied ML / Data Preparation & Cleaning — it falls under the category of AI platforms specialized in multi-omics & immunology data processing, predictive modeling, and mechanistic insight generation for drug discovery.

✏️ What does this tool offer?
Immunai is a biotechnology AI company that decodes the immune system using single-cell multi-omic data to guide therapeutic discovery. They generate, harmonize, and analyze immune data to build models that link immune features with treatment responses and inform clinical and preclinical decisions. 

⭐ What does the tool actually deliver based on user experience?
• Creation of high-resolution immune profiles (single-cell RNA, proteomics, TCR/BCR sequencing) from patient samples. 
• A unified immune atlas database, “AMICA”, combining internal and public immune datasets. 
• An AI engine (Immunodynamics Engine, IDE) that computes immune features, predicts response, and links mechanisms to outcomes. 
• Recommendations and explainable scoring (why certain immune signals are tied to clinical outcomes). 
• Use in target discovery, trial optimization (patient stratification, dose selection), and validating therapeutic hypotheses. 

🤖 Does it include automation?
Yes — Immunai automates multiple parts of the workflow:
• Processing and harmonizing multi-omic immune data (data ingestion, normalization). 
• Feature extraction and immune signature modeling via machine learning. 
• Hypothesis recommendation and scoring based on the computed models. 
• Integration of data with prior knowledge (AMICA) to support interpretability and benchmarking. 

💰 Pricing Model:
Enterprise / collaboration-based (custom pricing via partnerships with biopharma).

🆓 Free Plan Details:
No public free tier — access is likely via partnership or contracted collaborations.

💳 Paid Plan Details:
Contracts with pharma companies for use of ImmunaI’s AI and data platform, integration, and joint projects (e.g. collaboration with AstraZeneca). 

🧭 Access Method:
• Via Immunai’s cloud/AI platform and web interface.
• Through biopharma collaborations or project-based access.
• Integration into drug discovery workflows (preclinical, clinical) and data sharing agreements with partners.

🔗 Experience Link:

https://www.immunai.com

Pricing Details

💰 Pricing Model: Enterprise / collaboration-based (custom pricing via partnerships with biopharma). 🆓 Free Plan Details: No public free tier — access is likely via partnership or contracted collaborations. 💳 Paid Plan Details: Contracts with pharma companies for use of ImmunaI’s AI and data platform, integration, and joint projects (e.g. collaboration with AstraZeneca).